Status:
COMPLETED
Plaque Stratification Using Ccta in Coronary ARtery Disease (PoSTCARD)
Lead Sponsor:
Elucid Bioimaging Inc.
Collaborating Sponsors:
Medical University of South Carolina
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
Develop time-to-event prediction and plaque phenotype classification models for patients with known or suspected coronary artery disease.
Detailed Description
Develop time-to-event prediction and plaque phenotype classification models using plaque morphology and composition assessment of CTA which has been validated by histology, applied to representative c...
Eligibility Criteria
Inclusion
- Subject must have successfully completed at least one (possibly multiple) CCTA for known or suspected coronary artery disease, which was positive for coronary atherosclerotic changes.
- Subject must have been ≥ 18 years of age at the time of the CCTA
Exclusion
- Subject has a history of percutaneous coronary intervention (PCI) with stent implantation and/or coronary artery bypass grafting (CABG)
- CCTA taken less than 3 months after deployment of new scanner
- Subject with insufficient CCTA image quality
Key Trial Info
Start Date :
February 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2022
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04439643
Start Date
February 5 2020
End Date
July 30 2022
Last Update
September 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29425